Evida Biosciences
San Diego, US · Founded 2024 · Delaware corporation
Founders & leadership
MW
Michael WalshExecutive
Board
LO
Lauren OtsukiBoard director
SW
Shierley WidjajaBoard director
DW
David WrigleyBoard director
SG
Scott GlennBoard director
RB
Rolf BenirschkeBoard director
BG
Brian G. Feagan, M.D.Board director
Reported raises · per SEC filings
Form D private placements$42M disclosed across 1 round · 2024
▶$42MraisedOct 2024 · 26 investors · BiotechnologyRule 506(b)
▶$42MraisedOct 2024 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott GlennDirector
- Michael WalshExecutive Officer, Director
- Lauren OtsukiDirector
- Rolf BenirschkeDirector
- Shierley WidjajaDirector
- David WrigleyDirector
- Brian G. Feagan, M.D.Director
- Offering amount
- $42M
- Amount sold
- $42M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Evida Biosciences raised?
- Evida Biosciences has disclosed $42M raised across 1 round.
- Where is Evida Biosciences headquartered?
- Evida Biosciences is headquartered in San Diego, US.